NES and breast cancer: Nestin blockade has been shown to inhibit the proliferation of colorectal cancer cell lines [16], migration, invasion and stemness of lung adenocarcinoma lines [14] and a reduction in the 5-year survival rate has been verified in nestin-positive breast cancer patients [17].